Skip to content
Sectors How it works Pricing Client stories

Insights

Companies Live signals Events Markets Trends Company lists
Log in
Platform Signal Tracker API Radar Book a 7-day Readout
Diagnostics Biochem Canada (DBC) logo — Develop and market unique immunoassay kits that make a diffe...

Diagnostics Biochem Canada (DBC)

Develop and market unique immunoassay kits that make a difference in the field of diagnostics and in public health.

Founded 1973 Canada London, Canada 43 employees Biotechnology, Health Care +2

General Information

Company Name Diagnostics Biochem Canada (DBC)
Founded Year 1973
Location Canada London, Canada
Employees 43
Industries Biotechnology, Health Care, Manufacturing +1
Business Model B2B, B2G
Revenue Model Product Sales, One Time Purchase
Social

BounceWatch is an independent company data service, not affiliated with Diagnostics Biochem Canada (DBC). To contact Diagnostics Biochem Canada (DBC), visit dbc-labs.com.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

How does Diagnostics Biochem Canada (DBC) compare?

A PDF of Diagnostics Biochem Canada (DBC) and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.

See a sample report

This takes a few seconds: we look beyond our own index too.

Meeting Diagnostics Biochem Canada (DBC) soon?

A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample

About Diagnostics Biochem Canada (DBC)

Diagnostics Biochem Canada (DBC) has been a stalwart in the biotechnology and healthcare industries since its founding in 1973. Emphasizing innovation through its unique immunoassay kits, the company aligns itself with the broader goals of public health improvement and disease diagnosis.

With over five decades of expertise, DBC has carved out a niche in the global market by integrating emerging technologies such as 3D printing into its manufacturing processes. Headquartered in Canada, the firm is dedicated to advancing diagnostic quality, which speaks to its slogan: "Develop and market unique immunoassay kits that make a difference in the field of diagnostics and in public health."

Notably, the company has not recorded any recent external investment, a potential opportunity for investors to engage with a mature firm ready to scale further. The lack of recent investor activity suggests untapped potential for those seeking to drive future innovation in a proven enterprise with global impact.

Business keywords: immunoassay kits, diagnostics, public health, disease diagnosis, global market, diagnostic technologies, quality of life improvement, healthcare solutions, laboratory testing, medical manufacturing, scientific innovation, healthcare diagnostics, disease detection, biomedical research

Services & Products

development of immunoassay kits
manufacturing high-quality diagnostics
global distribution of diagnostic products

Target Customers

medical professionals diagnostic laboratories healthcare providers public health organizations

No funding data available for Diagnostics Biochem Canada (DBC) yet.

Diagnostics Biochem Canada (DBC) Alternatives & Competitors

View All Alternatives
Diagnostics Biochem Canada (DBC) vs
Fujirebio
Fujirebio Japan

A proven pioneer and partner to the diagnostics industry.

Venture round
726 employees
Biotechnology, Health Care
Diagnostics Biochem Canada (DBC) vs
Applied BioCode, Inc.
Applied BioCode, Inc. United States

The Ideal Choice for Cost-Effective High Throughput Syndromic Panels

Venture round
60 employees
Biotechnology, Health Care
Diagnostics Biochem Canada (DBC) vs
THORVACS Biotechnology
THORVACS Biotechnology Turkey

SALES | CONSULTING | LABORATORY | R&D

5 employees
Biotechnology, Digital Health
Also compare with: Diagnostics Biochem Canada (DBC) vs Bio-Rad Laboratories Bio-Rad Laboratories View all alternatives

FAQ About Diagnostics Biochem Canada (DBC)

Develop and market unique immunoassay kits that make a difference in the field of diagnostics and in public health.
Diagnostics Biochem Canada (DBC) was founded in 1973.
Diagnostics Biochem Canada (DBC) is headquartered in London, Canada.
Diagnostics Biochem Canada (DBC) operates in Biotechnology, Health Care, Manufacturing and 3D Printing. Its work centres on immunoassay kits, diagnostics, public health and disease diagnosis. Its customers include medical professionals, diagnostic laboratories and healthcare providers.
Diagnostics Biochem Canada (DBC) has a B2B and B2G business model. Its revenue comes from Product Sales and One Time Purchase.
Diagnostics Biochem Canada (DBC) has approximately 43 employees.
Diagnostics Biochem Canada (DBC) offers: development of immunoassay kits, manufacturing high-quality diagnostics, global distribution of diagnostic products.
Top alternatives and competitors to Diagnostics Biochem Canada (DBC) include Fujirebio, Applied BioCode, Inc., THORVACS Biotechnology, Mainz Biomed, EMPE Diagnostics. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Diagnostics Biochem Canada (DBC) and Fujirebio are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for Diagnostics Biochem Canada (DBC), https://bouncewatch.com/company/diagnostics-biochem-canada-dbc, updated 10 April 2026. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Talk to an analyst Book a 7-day Readout